Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Ticker SymbolCMND
Company nameClearmind Medicine Inc
IPO dateAug 10, 2021
CEODr. Adi Zuloff-Shani
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 10
Address101-1220 West 6Th Avenue
CityVANCOUVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeV6H 1A5
Phone16042601566
Websitehttps://www.clearmindmedicine.com/
Ticker SymbolCMND
IPO dateAug 10, 2021
CEODr. Adi Zuloff-Shani
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data